1-hexadecanoyl-2-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine

Term ID

CHEBI:84796

Synonyms

(2R)-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-3-(hexadecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate
(2R)-2-{[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy}-3-(hexadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
1-Palmitoyl-2-docosapentaenoyl-sn-glycero-3-phosphocholine
GPCho(16:0/22:5)
GPCho(16:0/22:5n3)
GPCho(16:0/22:5w3)
PC(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(16:0/22:5)
PC(16:0/22:5n3)
PC(16:0/22:5w3)
Phosphatidylcholine(16:0/22:5n3)
Phosphatidylcholine(16:0/22:5w3)

Definition

A phosphatidylcholine 38:5 in which the acyl groups at positions 1 and 2 are hexadecanoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidylcholine 38:5

phosphatidylcholine 38:5 Show first 5 Terms
has_functional_parent: (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid hexadecanoic acid

(7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid hexadecanoic acid Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 1-hexadecanoyl-2-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-hexadecanoyl-2-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-hexadecanoyl-2-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine

Human Disease Model